Conjugated antisense compounds and their use Grant US-10570169-B2 United States of America 25 Feb 2020
Oral formulations and lipophilic salts of methylnaltrexone Grant US-10507206-B2 United States of America 17 Dec 2019
Oral formulations and lipophilic salts of methylnaltrexone Grant US-10376505-B2 United States of America 13 Aug 2019
Stable pharmaceutical formulations of methylnaltrexone Grant US-10376584-B2 United States of America 13 Aug 2019
Oral formulations and lipophilic salts of methylnaltrexone Grant US-10307417-B2 United States of America 04 Jun 2019
Oral Drug Devices and Drug Formulations Application US-20160000881-A1 United States of America 07 Jan 2016
Oral Drug Devices and Drug Formulations Application US-20150238435-A1 United States of America 27 Aug 2015